FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143299323> ?p ?o ?g. }

• W2143299323 endingPage "376" @default.
• W2143299323 startingPage "367" @default.
• W2143299323 abstract "Aromatase inhibitor use for postmenopausal hormone-sensitive breast cancer patients often results in drug-induced osteoarthropathy, while its accurate mechanism has not been clarified. We investigated the implication of female hormones and several cytokines in osteoarthropathy complicated with aromatase inhibitor treatment, and the efficacy of vitamin E on the severity of osteoarthropathy, in breast cancer patients.Sixty two breast cancer patients treated with aromatase inhibitor for average of 1.77 years were included. These patients were orally administered vitamin E (150mg/day) for 29.8 days to alleviate aromatase inhibitor-related osteoarthropathy. Severity of osteoarthropathy was scored, and the patients were grouped based on the severity or vitamin E efficacy. Serum estradiol, progesterone, vitamin E, interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), IL-2, IL-4, IL-6, IL-10, and IL-17A concentrations were measured by ELISA or beads array procedures followed by flow cytometry.There was no significant difference in serum concentrations of the biomarkers between the severe and the mild osteoarthropathy groups before vitamin E administration. The osteoarthropathy scores significantly decreased after vitamin E administration (p=0.0243), while serum-estradiol concentrations did not change. The serum-estradiol concentrations before vitamin E administration in the group sensitive to the vitamin E efficacy were significantly lower, as compared with those in the insensitive group (p=0.0005). The rate of the highly sensitive patients to the vitamin E efficacy in those exhibiting low serum-estradiol concentrations was significantly higher than that in the high serum-estradiol group (p=0.0004). In the sensitive group, serum-estradiol concentrations after taking vitamin E were significantly higher than those before taking vitamin E (p=0.0124).Vitamin E administration seemed to be a potential way for relieving osteoarthropathy complicated with aromatase inhibitor use. Using serum-estradiol concentration, it would be possible to select out the breast cancer patients who will respond well to the vitamin E therapy for osteoarthropathy complicated with aromatase inhibitor." @default.
• W2143299323 created "2016-06-24" @default.
• W2143299323 creator A5017611425 @default.
• W2143299323 creator A5018902931 @default.
• W2143299323 creator A5040543323 @default.
• W2143299323 creator A5044398062 @default.
• W2143299323 creator A5050009780 @default.
• W2143299323 creator A5063623048 @default.
• W2143299323 creator A5063758486 @default.
• W2143299323 creator A5065243681 @default.
• W2143299323 date "2015-01-01" @default.
• W2143299323 modified "2023-09-28" @default.
• W2143299323 title "Clinical Significance of Female-hormones and Cytokines in Breast Cancer Patients Complicated with Aromatase Inhibitor-related Osteoarthropathy - Efficacy of Vitamin E" @default.
• W2143299323 cites W112314493 @default.
• W2143299323 cites W1566265989 @default.
• W2143299323 cites W1920804658 @default.
• W2143299323 cites W1984916905 @default.
• W2143299323 cites W1999460674 @default.
• W2143299323 cites W2009655951 @default.
• W2143299323 cites W2060551064 @default.
• W2143299323 cites W2068107397 @default.
• W2143299323 cites W2113172514 @default.
• W2143299323 cites W2116437320 @default.
• W2143299323 cites W2117025246 @default.
• W2143299323 cites W2119693147 @default.
• W2143299323 cites W2135261840 @default.
• W2143299323 cites W2145966851 @default.
• W2143299323 cites W2151027937 @default.
• W2143299323 cites W2153358660 @default.
• W2143299323 cites W2154583934 @default.
• W2143299323 cites W2159203244 @default.
• W2143299323 cites W2171467964 @default.
• W2143299323 doi "https://doi.org/10.7150/jca.10695" @default.
• W2143299323 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4349877" @default.
• W2143299323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25767607" @default.
• W2143299323 hasPublicationYear "2015" @default.
• W2143299323 type Work @default.
• W2143299323 sameAs 2143299323 @default.
• W2143299323 citedByCount "4" @default.
• W2143299323 countsByYear W21432993232017 @default.
• W2143299323 countsByYear W21432993232020 @default.
• W2143299323 countsByYear W21432993232023 @default.
• W2143299323 crossrefType "journal-article" @default.
• W2143299323 hasAuthorship W2143299323A5017611425 @default.
• W2143299323 hasAuthorship W2143299323A5018902931 @default.
• W2143299323 hasAuthorship W2143299323A5040543323 @default.
• W2143299323 hasAuthorship W2143299323A5044398062 @default.
• W2143299323 hasAuthorship W2143299323A5050009780 @default.
• W2143299323 hasAuthorship W2143299323A5063623048 @default.
• W2143299323 hasAuthorship W2143299323A5063758486 @default.
• W2143299323 hasAuthorship W2143299323A5065243681 @default.
• W2143299323 hasBestOaLocation W21432993231 @default.
• W2143299323 hasConcept C121608353 @default.
• W2143299323 hasConcept C124490489 @default.
• W2143299323 hasConcept C126322002 @default.
• W2143299323 hasConcept C134018914 @default.
• W2143299323 hasConcept C142724271 @default.
• W2143299323 hasConcept C182276654 @default.
• W2143299323 hasConcept C2776166826 @default.
• W2143299323 hasConcept C2776940978 @default.
• W2143299323 hasConcept C2778504769 @default.
• W2143299323 hasConcept C530470458 @default.
• W2143299323 hasConcept C71315377 @default.
• W2143299323 hasConcept C71924100 @default.
• W2143299323 hasConcept C90924648 @default.
• W2143299323 hasConceptScore W2143299323C121608353 @default.
• W2143299323 hasConceptScore W2143299323C124490489 @default.
• W2143299323 hasConceptScore W2143299323C126322002 @default.
• W2143299323 hasConceptScore W2143299323C134018914 @default.
• W2143299323 hasConceptScore W2143299323C142724271 @default.
• W2143299323 hasConceptScore W2143299323C182276654 @default.
• W2143299323 hasConceptScore W2143299323C2776166826 @default.
• W2143299323 hasConceptScore W2143299323C2776940978 @default.
• W2143299323 hasConceptScore W2143299323C2778504769 @default.
• W2143299323 hasConceptScore W2143299323C530470458 @default.
• W2143299323 hasConceptScore W2143299323C71315377 @default.
• W2143299323 hasConceptScore W2143299323C71924100 @default.
• W2143299323 hasConceptScore W2143299323C90924648 @default.
• W2143299323 hasIssue "4" @default.
• W2143299323 hasLocation W21432993231 @default.
• W2143299323 hasLocation W21432993232 @default.
• W2143299323 hasLocation W21432993233 @default.
• W2143299323 hasLocation W21432993234 @default.
• W2143299323 hasLocation W21432993235 @default.
• W2143299323 hasOpenAccess W2143299323 @default.
• W2143299323 hasPrimaryLocation W21432993231 @default.
• W2143299323 hasRelatedWork W164398201 @default.
• W2143299323 hasRelatedWork W2012733509 @default.
• W2143299323 hasRelatedWork W2110010322 @default.
• W2143299323 hasRelatedWork W2125067565 @default.
• W2143299323 hasRelatedWork W2127707841 @default.
• W2143299323 hasRelatedWork W2131241813 @default.
• W2143299323 hasRelatedWork W2132450885 @default.
• W2143299323 hasRelatedWork W2136688633 @default.
• W2143299323 hasRelatedWork W2169905015 @default.
• W2143299323 hasRelatedWork W2926335606 @default.
• W2143299323 hasVolume "6" @default.
• W2143299323 isParatext "false" @default.

• next